A Clinical Trial to Study the Effects of Bobath Therapy With and Without EMG Biofeedback Therapy in Stroke Patients
Launched by NATIONAL INSTITUTE FOR LOCOMOTOR DISABILITIES (DIVYANGJAN), INDIA · Jul 11, 2023
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is investigating the effects of two different types of therapy on patients who have had a stroke. The therapies being studied are called Bobath therapy and EMG Biofeedback therapy. Bobath therapy focuses on improving movement and coordination, while EMG Biofeedback therapy uses special equipment to help patients learn how to control their muscles better. The goal of this trial is to see if combining these two therapies is more effective than just using Bobath therapy alone in helping stroke patients improve their ability to walk, balance, and perform daily activities.
To participate in the study, individuals must be between 40 and 65 years old and have had their first stroke within the last three months to three years. They should have some movement ability and not have any major cognitive issues. However, those with vision problems, sensory deficits, or other serious medical conditions won't be eligible. Participants can expect to receive therapy sessions that may help them regain strength and balance, and they will be closely monitored throughout the trial. This research could provide valuable insights into the best ways to support recovery for stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Both male and female patients aged between 40 - 65 years.
- • 2. Patients with first attack of stroke, diagnosed by a physician.
- • 3. Duration of stroke 3 months to 3 years.
- • 4. Patient has no cognitive impairment and has a MMSE Score ≥ 24.
- • 5. Grade of spasticity upto 2 in lower extremity on Modified Ashworth Scale.
- • 6. Patient is in Brunnstrom lower limb recovery stage 3 and 4.
- • 7. Patient should have passive 10° or greater ankle dorsiflexion.
- • 8. Patient can sit independently on a plinth.
- • 9. Patient should be ambulatory either independently or with some assistive aid.
- Exclusion Criteria:
- • 1. Patient with any sensory deficit of the lower extremity.
- • 2. Problems with vision, like - homonymous hemianopsia, hemiagnosia, visual agnosia etc.
- • 3. Patients with hearing loss.
- • 4. Patients with hemineglect.
- • 5. Patients with sensory, conduction or global aphasia.
- • 6. Musculoskeletal conditions like - fracture, contracture and deformity in lower extremity.
- • 7. Diagnosed neurological diseases like - Parkinsonism, Dementia, Peripheral nerve injury in the lower extremity etc.
- • 8. Diagnosed systemic diseases like - uncontrolled hypertension etc. and/or peripheral vascular disease in lower extremity like - Raynaud's disease etc.
About National Institute For Locomotor Disabilities (Divyangjan), India
The National Institute for Locomotor Disabilities (Divyangjan) in India is a premier research and clinical institution dedicated to improving the quality of life for individuals with locomotor disabilities. As a sponsor of clinical trials, the Institute focuses on innovative research and development of therapeutic interventions, rehabilitation strategies, and assistive technologies. With a commitment to advancing knowledge and fostering collaboration, the Institute aims to enhance evidence-based practices and contribute to the global body of research in disability management. Through its initiatives, the National Institute for Locomotor Disabilities seeks to empower individuals and promote inclusivity within society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kolkata, West Bengal, India
Patients applied
Trial Officials
Sanlap Kundu, BPT
Principal Investigator
The West Bengal University of Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported